Literature DB >> 11477262

Quantitative assessment of dural ectasia as a marker for Marfan syndrome.

T Oosterhof1, M Groenink, F J Hulsmans, B J Mulder, E E van der Wall, R Smit, R C Hennekam.   

Abstract

PURPOSE: To establish normal values for lumbosacral dural sac dimensions with magnetic resonance (MR) imaging and to use these values to assess the sensitivity and specificity of dural ectasia as a marker for Marfan syndrome.
MATERIALS AND METHODS: MR imaging was performed to measure dural sac diameter (DSD) from L1 through S1 in 44 adult patients with Marfan syndrome and in 44 matched control subjects. DSD values were corrected for vertebral body size, yielding dural sac ratios (DSRs). The control subjects served to establish the upper limit of normal DSR values at the L1 through S1 levels.
RESULTS: Cutoff values for normal DSRs for L1 through S1 were 0.64, 0.55, 0.47, 0.48, 0.48, and 0.57. Significant DSR differences were shown at all levels between patients with Marfan syndrome and control subjects (P <.001 at all levels). At L1 through S1, the sensitivity of dural ectasia as a marker for Marfan syndrome was 45%-77%, and the specificity was 95% or greater. By combining levels L3 and S1, dural ectasia as a marker for Marfan syndrome yielded a sensitivity of 95% (42 of 44 patients) and a specificity of 98% (43 of 44). The presence of dural ectasia excelled, compared with the presence of other Marfan syndrome manifestations in the patient population.
CONCLUSION: Abnormal DSR values at L3 or S1 can be used to identify Marfan syndrome with 95% sensitivity and 98% specificity.

Entities:  

Mesh:

Year:  2001        PMID: 11477262     DOI: 10.1148/radiology.220.2.r01au08514

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  21 in total

Review 1.  Marfan syndrome. Part 1: pathophysiology and diagnosis.

Authors:  Victoria Cañadas; Isidre Vilacosta; Isidoro Bruna; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2010-03-30       Impact factor: 32.419

2.  Duchenne muscular dystrophy; a cardiomyopathy that can be prevented?

Authors:  Barbara J M Mulder; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2008-10-01       Impact factor: 2.357

3.  Project report: adult congenital heart disease.

Authors:  B J M Mulder
Journal:  Neth Heart J       Date:  2002-11       Impact factor: 2.380

Review 4.  Non-cardiac manifestations of Marfan syndrome.

Authors:  Anne H Child
Journal:  Ann Cardiothorac Surg       Date:  2017-11

5.  Dural ectasia in adolescent idiopathic scoliosis: quantitative assessment on magnetic resonance imaging.

Authors:  Kasim Abul-Kasim; Angelica Overgaard; Acke Ohlin
Journal:  Eur Spine J       Date:  2010-03-09       Impact factor: 3.134

Review 6.  Marfan's syndrome and the heart.

Authors:  Alan Graham Stuart; Andrew Williams
Journal:  Arch Dis Child       Date:  2007-04       Impact factor: 3.791

7.  Radiographic Morphometry of the Lumbar Spine in Munich Miniature Pigs.

Authors:  Elisabeth C Engelke; Christina Post; Christiane D Pfarrer; Martin Sager; Helmut R Waibl
Journal:  J Am Assoc Lab Anim Sci       Date:  2016       Impact factor: 1.232

8.  Prevalence data on all Ghent features in a cross-sectional study of 87 adults with proven Marfan syndrome.

Authors:  Svend Rand-Hendriksen; Rigmor Lundby; Lena Tjeldhorn; Kai Andersen; Jon Offstad; Svein Ove Semb; Hans-Jørgen Smith; Benedicte Paus; Odd Geiran
Journal:  Eur J Hum Genet       Date:  2009-03-18       Impact factor: 4.246

9.  Performance of a new quantitative method for assessing dural ectasia in patients with FBN1 mutations and clinical features of Marfan syndrome.

Authors:  Bahar Söylen; Kerstin Hinz; Jana Prokein; Hartmut Becker; Jörg Schmidtke; Mine Arslan-Kirchner
Journal:  Neuroradiology       Date:  2009-02-19       Impact factor: 2.804

10.  Spinal imaging features in Japanese patients with Marfan syndrome: a case-control study.

Authors:  Eri Hayashida; Daisuke Utsunomiya; Akira Sasao; Tsuyoshi Yasuda; Toshinori Hirai; Hideaki Yuki; Seitaro Oda; Joji Urata; Akihiko Arakawa; Yasuyuki Yamashita
Journal:  Jpn J Radiol       Date:  2014-01-30       Impact factor: 2.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.